{"transactions":[{"id":4636999,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-10-07T20:12:07.000Z","date":"2026-10-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17948,"price":5,"value":89740.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026."}],"balance_after":14328,"source":{"system":"sec-edgar","filing":"0001447028-26-000061","document":"wk-form4_1791403925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000061/wk-form4_1791403925.xml","form_type":"4"}},{"id":4636998,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-10-07T20:11:41.000Z","date":"2026-10-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":48081,"price":5,"value":240405.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026."}],"balance_after":111882,"source":{"system":"sec-edgar","filing":"0001447028-26-000060","document":"wk-form4_1791403899.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000060/wk-form4_1791403899.xml","form_type":"4"}},{"id":4636984,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-10-07T20:09:53.000Z","date":"2026-10-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17142,"price":5,"value":85710.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026."}],"balance_after":13683,"source":{"system":"sec-edgar","filing":"0001447028-26-000059","document":"wk-form4_1791403791.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702826000059/wk-form4_1791403791.xml","form_type":"4"}},{"id":4636981,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-10-07T20:09:10.000Z","date":"2026-10-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24655,"price":5,"value":123275.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026."}],"balance_after":47682,"source":{"system":"sec-edgar","filing":"0001447028-26-000058","document":"wk-form4_1791403746.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936604/000144702826000058/wk-form4_1791403746.xml","form_type":"4"}},{"id":4631549,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV","position":1,"cik":"0001635088","reported_name":"Roivant Sciences Ltd.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2026-10-06T01:00:29.000Z","date":"2026-10-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8967383,"price":5,"value":44836915.0,"ownership":{"direct":true},"balance_after":29880079,"source":{"system":"sec-edgar","filing":"0001140361-26-038692","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126038692/form4.xml","form_type":"4"}},{"id":4625871,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:32:24.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":10456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 71,700 shares, vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the February 2, 2026 grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":61244,"derivative":{"exercise_price":4.39,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":10456},"source":{"system":"sec-edgar","filing":"0001447028-26-000053","document":"wk-form4_1790209942.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1936604/000144702826000053/wk-form4_1790209942.xml","form_type":"4"}},{"id":4625870,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:32:24.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":116408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 310,422 shares, vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the March 18, 2025 grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":194014,"derivative":{"exercise_price":3.2,"expiration_date":"2035-03-18","underlying":"Common Shares","underlying_shares":116408},"source":{"system":"sec-edgar","filing":"0001447028-26-000053","document":"wk-form4_1790209942.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1936604/000144702826000053/wk-form4_1790209942.xml","form_type":"4"}},{"id":4625869,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-09-24T00:32:24.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":82527,"price":5.07,"value":418411.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised options on September 18, 2026. The Issuer withheld an aggregate of 82,527 shares otherwise issuable upon the exercises to satisfy the aggregate exercise prices."}],"balance_after":72337,"source":{"system":"sec-edgar","filing":"0001447028-26-000053","document":"wk-form4_1790209942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1936604/000144702826000053/wk-form4_1790209942.xml","form_type":"4"}},{"id":4625868,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-09-24T00:32:24.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":10456,"price":4.39,"value":45901.84,"ownership":{"direct":true},"balance_after":154864,"source":{"system":"sec-edgar","filing":"0001447028-26-000053","document":"wk-form4_1790209942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1936604/000144702826000053/wk-form4_1790209942.xml","form_type":"4"}},{"id":4625867,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-09-24T00:32:24.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":116408,"price":3.2,"value":372505.6,"ownership":{"direct":true},"balance_after":144408,"source":{"system":"sec-edgar","filing":"0001447028-26-000053","document":"wk-form4_1790209942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936604/000144702826000053/wk-form4_1790209942.xml","form_type":"4"}},{"id":4625866,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:31:52.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":27475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 188,400 shares, vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the February 2, 2026 grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":160925,"derivative":{"exercise_price":4.39,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":27475},"source":{"system":"sec-edgar","filing":"0001447028-26-000052","document":"wk-form4_1790209910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000052/wk-form4_1790209910.xml","form_type":"4"}},{"id":4625865,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:31:52.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":265625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 750,000 shares, vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the March 31, 2025 grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":484375,"derivative":{"exercise_price":3.49,"expiration_date":"2035-03-31","underlying":"Common Shares","underlying_shares":265625},"source":{"system":"sec-edgar","filing":"0001447028-26-000052","document":"wk-form4_1790209910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000052/wk-form4_1790209910.xml","form_type":"4"}},{"id":4625864,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-09-24T00:31:52.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":206637,"price":5.07,"value":1047649.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised options on September 18, 2026. The Issuer withheld an aggregate of 206,637 shares otherwise issuable upon the exercises to satisfy the aggregate exercise prices."}],"balance_after":159963,"source":{"system":"sec-edgar","filing":"0001447028-26-000052","document":"wk-form4_1790209910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000052/wk-form4_1790209910.xml","form_type":"4"}},{"id":4625863,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-09-24T00:31:52.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":27475,"price":4.39,"value":120615.25,"ownership":{"direct":true},"balance_after":366600,"source":{"system":"sec-edgar","filing":"0001447028-26-000052","document":"wk-form4_1790209910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000052/wk-form4_1790209910.xml","form_type":"4"}},{"id":4625862,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-09-24T00:31:52.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":265625,"price":3.49,"value":927031.25,"ownership":{"direct":true},"balance_after":339125,"source":{"system":"sec-edgar","filing":"0001447028-26-000052","document":"wk-form4_1790209910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000052/wk-form4_1790209910.xml","form_type":"4"}},{"id":4625861,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:31:17.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":78800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 78,800 shares, was fully vested and exercisable as of the June 8, 2026 grant date."}],"balance_after":0,"derivative":{"exercise_price":4.24,"exercise_date":"2026-06-08","expiration_date":"2036-06-08","underlying":"Common Shares","underlying_shares":78800},"source":{"system":"sec-edgar","filing":"0001447028-26-000051","document":"wk-form4_1790209875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702826000051/wk-form4_1790209875.xml","form_type":"4"}},{"id":4625860,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:31:17.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":52533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 157,600 shares, vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd and 3rd anniversaries of the August 4, 2025 grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":105067,"derivative":{"exercise_price":3.34,"expiration_date":"2035-08-04","underlying":"Common Shares","underlying_shares":52533},"source":{"system":"sec-edgar","filing":"0001447028-26-000051","document":"wk-form4_1790209875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702826000051/wk-form4_1790209875.xml","form_type":"4"}},{"id":4625859,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-24T00:31:17.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":100508,"price":5.07,"value":509575.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised options on September 18, 2026. The Issuer withheld an aggregate of 100,508 shares otherwise issuable upon the exercises to satisfy the aggregate exercise prices."}],"balance_after":30825,"source":{"system":"sec-edgar","filing":"0001447028-26-000051","document":"wk-form4_1790209875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702826000051/wk-form4_1790209875.xml","form_type":"4"}},{"id":4625858,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-24T00:31:17.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":78800,"price":4.24,"value":334112.0,"ownership":{"direct":true},"balance_after":131333,"source":{"system":"sec-edgar","filing":"0001447028-26-000051","document":"wk-form4_1790209875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702826000051/wk-form4_1790209875.xml","form_type":"4"}},{"id":4625857,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-24T00:31:17.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":52533,"price":3.34,"value":175460.22,"ownership":{"direct":true},"balance_after":52533,"source":{"system":"sec-edgar","filing":"0001447028-26-000051","document":"wk-form4_1790209875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702826000051/wk-form4_1790209875.xml","form_type":"4"}},{"id":4625856,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:31:01.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":78800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 78,800 shares, was fully vested and exercisable as of the June 8, 2026 grant date."}],"balance_after":0,"derivative":{"exercise_price":4.24,"exercise_date":"2026-06-08","expiration_date":"2036-06-08","underlying":"Common Shares","underlying_shares":78800},"source":{"system":"sec-edgar","filing":"0001447028-26-000050","document":"wk-form4_1790209858.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000050/wk-form4_1790209858.xml","form_type":"4"}},{"id":4625855,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:31:01.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":52533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 157,600 shares, vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd and 3rd anniversaries of the March 18, 2025 grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":105067,"derivative":{"exercise_price":3.2,"expiration_date":"2035-03-18","underlying":"Common Shares","underlying_shares":52533},"source":{"system":"sec-edgar","filing":"0001447028-26-000050","document":"wk-form4_1790209858.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000050/wk-form4_1790209858.xml","form_type":"4"}},{"id":4625854,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-24T00:31:01.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":99057,"price":5.07,"value":502218.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised options on September 18, 2026. The Issuer withheld an aggregate of 99,057 shares otherwise issuable upon the exercises to satisfy the aggregate exercise prices."}],"balance_after":32276,"source":{"system":"sec-edgar","filing":"0001447028-26-000050","document":"wk-form4_1790209858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000050/wk-form4_1790209858.xml","form_type":"4"}},{"id":4625853,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-24T00:31:01.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":78800,"price":4.24,"value":334112.0,"ownership":{"direct":true},"balance_after":131333,"source":{"system":"sec-edgar","filing":"0001447028-26-000050","document":"wk-form4_1790209858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000050/wk-form4_1790209858.xml","form_type":"4"}},{"id":4625852,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-24T00:31:01.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":52533,"price":3.2,"value":168105.6,"ownership":{"direct":true},"balance_after":52533,"source":{"system":"sec-edgar","filing":"0001447028-26-000050","document":"wk-form4_1790209858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000050/wk-form4_1790209858.xml","form_type":"4"}},{"id":743285,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:05:32.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":78800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":78800,"derivative":{"exercise_price":4.24,"exercise_date":"2026-06-08","expiration_date":"2036-06-08","underlying":"Common Shares","underlying_shares":78800},"source":{"system":"sec-edgar","filing":"0001447028-26-000040","document":"wk-form4_1781121928.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702826000040/wk-form4_1781121928.xml","form_type":"4"}},{"id":743030,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:05:24.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":78800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":78800,"derivative":{"exercise_price":4.24,"exercise_date":"2026-06-08","expiration_date":"2036-06-08","underlying":"Common Shares","underlying_shares":78800},"source":{"system":"sec-edgar","filing":"0001447028-26-000039","document":"wk-form4_1781121921.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000039/wk-form4_1781121921.xml","form_type":"4"}},{"id":924840,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T01:21:13.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":71700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":71700,"derivative":{"exercise_price":4.39,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":71700},"source":{"system":"sec-edgar","filing":"0001447028-26-000008","document":"wk-form4_1770081671.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000008/wk-form4_1770081671.xml","form_type":"4"}},{"id":924839,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-02-03T01:21:13.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":28000,"source":{"system":"sec-edgar","filing":"0001447028-26-000008","document":"wk-form4_1770081671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000008/wk-form4_1770081671.xml","form_type":"4"}},{"id":925586,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T20:21:34.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":188400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":188400,"derivative":{"exercise_price":4.39,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":188400},"source":{"system":"sec-edgar","filing":"0001447028-26-000009","document":"wk-form4_1770081692.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000009/wk-form4_1770081692.xml","form_type":"4"}},{"id":925585,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-02-02T20:21:34.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":73500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":73500,"source":{"system":"sec-edgar","filing":"0001447028-26-000009","document":"wk-form4_1770081692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000009/wk-form4_1770081692.xml","form_type":"4"}},{"id":1073192,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-06T20:08:29.000Z","date":"2025-08-04","kind":"grant","planned":false,"acquired":true,"shares":157600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd, and 3rd anniversaries of the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":157600,"derivative":{"exercise_price":3.34,"expiration_date":"2035-08-04","underlying":"Common Shares","underlying_shares":157600},"source":{"system":"sec-edgar","filing":"0001447028-25-000120","document":"wk-form4_1754510902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702825000120/wk-form4_1754510902.xml","form_type":"4"}},{"id":1186814,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-01T17:47:47.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":750000,"derivative":{"exercise_price":3.49,"expiration_date":"2035-03-31","underlying":"Common Shares","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001447028-25-000090","document":"wk-form4a_1743544061.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702825000090/wk-form4a_1743544061.xml","form_type":"4/A","original_submission_date":"2025-03-31"}},{"id":1188201,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-31T16:24:03.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":750000,"derivative":{"exercise_price":3.5,"expiration_date":"2035-03-31","underlying":"Common Shares","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001447028-25-000088","document":"wk-form4_1743452635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702825000088/wk-form4_1743452635.xml","form_type":"4"}},{"id":1195596,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-20T20:10:16.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":157600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd, and 3rd anniversaries of the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":157600,"derivative":{"exercise_price":3.2,"expiration_date":"2035-03-18","underlying":"Common Shares","underlying_shares":157600},"source":{"system":"sec-edgar","filing":"0001447028-25-000075","document":"wk-form4_1742501408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702825000075/wk-form4_1742501408.xml","form_type":"4"}},{"id":1195597,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-20T20:08:32.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":310422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":310422,"derivative":{"exercise_price":3.2,"expiration_date":"2035-03-18","underlying":"Common Shares","underlying_shares":310422},"source":{"system":"sec-edgar","filing":"0001447028-25-000072","document":"wk-form4_1742501306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702825000072/wk-form4_1742501306.xml","form_type":"4"}},{"id":1195947,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":81723,"kind":"person","name":"Hasija Anuj","position":1,"cik":"0002058570","reported_name":"Hasija Anuj","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-20T16:14:12.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":157600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd, and 3rd anniversaries of the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":157600,"derivative":{"exercise_price":3.2,"expiration_date":"2035-03-18","underlying":"Common Shares","underlying_shares":157600},"source":{"system":"sec-edgar","filing":"0001447028-25-000077","document":"wk-form4_1742501645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058570/000144702825000077/wk-form4_1742501645.xml","form_type":"4"}},{"id":1259700,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-19T23:25:40.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":718800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":718800,"derivative":{"exercise_price":3.29,"expiration_date":"2035-02-14","underlying":"Common Shares","underlying_shares":718800},"source":{"system":"sec-edgar","filing":"0001447028-25-000051","document":"wk-form4_1740007534.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702825000051/wk-form4_1740007534.xml","form_type":"4"}},{"id":1259699,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Common Shares","published_at":"2025-02-19T23:25:40.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":177000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":1658003,"source":{"system":"sec-edgar","filing":"0001447028-25-000051","document":"wk-form4_1740007534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702825000051/wk-form4_1740007534.xml","form_type":"4"}},{"id":1259698,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34527,"kind":"person","name":"HASTINGS DAVID C","position":1,"cik":"0001237401","reported_name":"HASTINGS DAVID C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-19T23:25:30.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":365800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":365800,"derivative":{"exercise_price":3.29,"expiration_date":"2035-02-14","underlying":"Common Shares","underlying_shares":365800},"source":{"system":"sec-edgar","filing":"0001447028-25-000050","document":"wk-form4_1740007524.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702825000050/wk-form4_1740007524.xml","form_type":"4"}},{"id":1259697,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34527,"kind":"person","name":"HASTINGS DAVID C","position":1,"cik":"0001237401","reported_name":"HASTINGS DAVID C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-02-19T23:25:30.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":90100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":249824,"source":{"system":"sec-edgar","filing":"0001447028-25-000050","document":"wk-form4_1740007524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702825000050/wk-form4_1740007524.xml","form_type":"4"}},{"id":1259822,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83058,"kind":"person","name":"Naftzger J. Christopher","position":1,"cik":"0001496194","reported_name":"Naftzger J. Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-19T18:25:53.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":220300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":220300,"derivative":{"exercise_price":3.29,"expiration_date":"2035-02-14","underlying":"Common Shares","underlying_shares":220300},"source":{"system":"sec-edgar","filing":"0001447028-25-000052","document":"wk-form4_1740007544.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496194/000144702825000052/wk-form4_1740007544.xml","form_type":"4"}},{"id":1259821,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83058,"kind":"person","name":"Naftzger J. Christopher","position":1,"cik":"0001496194","reported_name":"Naftzger J. Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Shares","published_at":"2025-02-19T18:25:53.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":54300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":140544,"source":{"system":"sec-edgar","filing":"0001447028-25-000052","document":"wk-form4_1740007544.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496194/000144702825000052/wk-form4_1740007544.xml","form_type":"4"}},{"id":1260589,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83069,"kind":"person","name":"Sims Karen","position":1,"cik":"0001984652","reported_name":"Sims Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-19T18:25:20.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":200300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":200300,"derivative":{"exercise_price":3.29,"expiration_date":"2035-02-14","underlying":"Common Shares","underlying_shares":200300},"source":{"system":"sec-edgar","filing":"0001447028-25-000049","document":"wk-form4_1740007514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1984652/000144702825000049/wk-form4_1740007514.xml","form_type":"4"}},{"id":1260588,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83069,"kind":"person","name":"Sims Karen","position":1,"cik":"0001984652","reported_name":"Sims Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2025-02-19T18:25:20.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":49300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":155494,"source":{"system":"sec-edgar","filing":"0001447028-25-000049","document":"wk-form4_1740007514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1984652/000144702825000049/wk-form4_1740007514.xml","form_type":"4"}},{"id":1281714,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34527,"kind":"person","name":"HASTINGS DAVID C","position":1,"cik":"0001237401","reported_name":"HASTINGS DAVID C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-02-05T21:02:55.000Z","date":"2025-02-04","kind":"sale","planned":true,"acquired":false,"shares":22183,"price":3.283,"value":72826.789,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 6, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of previous grants of restricted stock units."}],"balance_after":159724,"source":{"system":"sec-edgar","filing":"0001447028-25-000040","document":"wk-form4_1738789366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702825000040/wk-form4_1738789366.xml","form_type":"4"}},{"id":1281713,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Common Shares","published_at":"2025-02-05T21:02:29.000Z","date":"2025-02-04","kind":"sale","planned":true,"acquired":false,"shares":23790,"price":3.283,"value":78102.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 3, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of previous grants of restricted stock units."}],"balance_after":1481003,"source":{"system":"sec-edgar","filing":"0001447028-25-000038","document":"wk-form4_1738789341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702825000038/wk-form4_1738789341.xml","form_type":"4"}},{"id":1282252,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83069,"kind":"person","name":"Sims Karen","position":1,"cik":"0001984652","reported_name":"Sims Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2025-02-05T16:02:43.000Z","date":"2025-02-04","kind":"sale","planned":true,"acquired":false,"shares":19348,"price":3.283,"value":63519.484,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 9, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of previous grants of restricted stock units."}],"balance_after":106194,"source":{"system":"sec-edgar","filing":"0001447028-25-000039","document":"wk-form4_1738789353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1984652/000144702825000039/wk-form4_1738789353.xml","form_type":"4"}},{"id":1281823,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83058,"kind":"person","name":"Naftzger J. Christopher","position":1,"cik":"0001496194","reported_name":"Naftzger J. Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Shares","published_at":"2025-02-05T16:02:16.000Z","date":"2025-02-04","kind":"sale","planned":true,"acquired":false,"shares":11333,"price":3.283,"value":37206.239,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on July 11, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of previous grants of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,214 and 1,263 shares acquired under the Arbutus Biopharma Corporation 2020 Employee Stock Purchase Plan on February 29, 2024 and August 30, 2024, respectively."}],"balance_after":86244,"source":{"system":"sec-edgar","filing":"0001447028-25-000037","document":"wk-form4_1738789328.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496194/000144702825000037/wk-form4_1738789328.xml","form_type":"4"}},{"id":1431246,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-16T20:07:41.000Z","date":"2024-08-14","kind":"exercise","planned":false,"acquired":false,"shares":54915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cashless exercise and hold transaction in director stock options due to expire on November 13, 2024, ten years after such options were granted, including the sale of 8,846 of the underlying shares to pay the exercise price. None of the net 46,069 shares were sold."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This is a director stock option grant that is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.56,"expiration_date":"2024-11-13","underlying":"Common Shares","underlying_shares":54915},"source":{"system":"sec-edgar","filing":"0001447028-24-000078","document":"wk-form4_1723838854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000078/wk-form4_1723838854.xml","form_type":"4"}},{"id":1431245,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-08-16T20:07:41.000Z","date":"2024-08-14","kind":"sale","planned":false,"acquired":false,"shares":8846,"price":3.6895,"value":32637.317,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cashless exercise and hold transaction in director stock options due to expire on November 13, 2024, ten years after such options were granted, including the sale of 8,846 of the underlying shares to pay the exercise price. None of the net 46,069 shares were sold."}],"balance_after":46069,"source":{"system":"sec-edgar","filing":"0001447028-24-000078","document":"wk-form4_1723838854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000078/wk-form4_1723838854.xml","form_type":"4"}},{"id":1431244,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-08-16T20:07:41.000Z","date":"2024-08-14","kind":"exercise","planned":false,"acquired":true,"shares":54915,"price":0.56,"value":30752.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cashless exercise and hold transaction in director stock options due to expire on November 13, 2024, ten years after such options were granted, including the sale of 8,846 of the underlying shares to pay the exercise price. None of the net 46,069 shares were sold."}],"balance_after":54915,"source":{"system":"sec-edgar","filing":"0001447028-24-000078","document":"wk-form4_1723838854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000078/wk-form4_1723838854.xml","form_type":"4"}},{"id":1501884,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":69834,"kind":"person","name":"BURGESS DANIEL D","position":1,"cik":"0001239650","reported_name":"BURGESS DANIEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-24T20:17:52.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":67000,"derivative":{"exercise_price":3.28,"exercise_date":"2024-05-23","expiration_date":"2034-05-23","underlying":"Common Shares","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001447028-24-000059","document":"wk-form4_1716581859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000059/wk-form4_1716581859.xml","form_type":"4"}},{"id":1501883,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-24T20:16:11.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":67000,"derivative":{"exercise_price":3.28,"exercise_date":"2024-05-23","expiration_date":"2034-05-23","underlying":"Common Shares","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001447028-24-000057","document":"wk-form4_1716581747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000057/wk-form4_1716581747.xml","form_type":"4"}},{"id":1502141,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-24T20:14:32.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":67000,"derivative":{"exercise_price":3.28,"exercise_date":"2024-05-23","expiration_date":"2034-05-23","underlying":"Common Shares","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001447028-24-000055","document":"wk-form4_1716581649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000144702824000055/wk-form4_1716581649.xml","form_type":"4"}},{"id":1501885,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-24T20:12:52.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":67000,"derivative":{"exercise_price":3.28,"exercise_date":"2024-05-23","expiration_date":"2034-05-23","underlying":"Common Shares","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001447028-24-000053","document":"wk-form4_1716581555.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000053/wk-form4_1716581555.xml","form_type":"4"}},{"id":1501882,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":90604,"kind":"person","name":"Rewolinski Melissa","position":1,"cik":"0001780206","reported_name":"Rewolinski Melissa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-24T20:10:50.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":67000,"derivative":{"exercise_price":3.28,"exercise_date":"2024-05-23","expiration_date":"2034-05-23","underlying":"Common Shares","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001447028-24-000051","document":"wk-form4_1716581426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000051/wk-form4_1716581426.xml","form_type":"4"}},{"id":1501881,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":32849,"kind":"person","name":"Torti Frank","position":1,"cik":"0001647805","reported_name":"Torti Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-24T20:07:10.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":67000,"derivative":{"exercise_price":3.28,"exercise_date":"2024-05-23","expiration_date":"2034-05-23","underlying":"Common Shares","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001447028-24-000049","document":"wk-form4_1716581215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000049/wk-form4_1716581215.xml","form_type":"4"}},{"id":1658670,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34527,"kind":"person","name":"HASTINGS DAVID C","position":1,"cik":"0001237401","reported_name":"HASTINGS DAVID C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-06T00:54:49.000Z","date":"2024-02-01","kind":"grant","planned":true,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":450000,"derivative":{"exercise_price":2.4,"expiration_date":"2034-02-01","underlying":"Common Shares","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001447028-24-000027","document":"wk-form4_1707180869.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000027/wk-form4_1707180869.xml","form_type":"4"}},{"id":1658669,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34527,"kind":"person","name":"HASTINGS DAVID C","position":1,"cik":"0001237401","reported_name":"HASTINGS DAVID C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2024-02-06T00:54:49.000Z","date":"2024-02-02","kind":"sale","planned":true,"acquired":false,"shares":9593,"price":2.3125,"value":22183.8125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on  March 6, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of a previous grant of restricted stock units."}],"balance_after":181907,"source":{"system":"sec-edgar","filing":"0001447028-24-000027","document":"wk-form4_1707180869.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000027/wk-form4_1707180869.xml","form_type":"4"}},{"id":1658668,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34527,"kind":"person","name":"HASTINGS DAVID C","position":1,"cik":"0001237401","reported_name":"HASTINGS DAVID C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2024-02-06T00:54:49.000Z","date":"2024-02-01","kind":"grant","planned":true,"acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":191500,"source":{"system":"sec-edgar","filing":"0001447028-24-000027","document":"wk-form4_1707180869.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000027/wk-form4_1707180869.xml","form_type":"4"}},{"id":1658665,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-06T00:54:25.000Z","date":"2024-02-01","kind":"grant","planned":true,"acquired":true,"shares":437800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":437800,"derivative":{"exercise_price":2.4,"expiration_date":"2034-02-01","underlying":"Common Shares","underlying_shares":437800},"source":{"system":"sec-edgar","filing":"0001447028-24-000026","document":"wk-form4_1707180851.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000026/wk-form4_1707180851.xml","form_type":"4"}},{"id":1658664,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2024-02-06T00:54:25.000Z","date":"2024-02-02","kind":"sale","planned":true,"acquired":false,"shares":9982,"price":2.3125,"value":23083.375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 5, 2023,  to satisfy the Reporting Person's tax obligations with respect to the vesting of a previous grant of restricted stock units."}],"balance_after":1485121,"source":{"system":"sec-edgar","filing":"0001447028-24-000026","document":"wk-form4_1707180851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000026/wk-form4_1707180851.xml","form_type":"4"}},{"id":1658663,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2024-02-06T00:54:25.000Z","date":"2024-02-01","kind":"grant","planned":true,"acquired":true,"shares":109500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":1495103,"source":{"system":"sec-edgar","filing":"0001447028-24-000026","document":"wk-form4_1707180851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000026/wk-form4_1707180851.xml","form_type":"4"}},{"id":1658662,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-06T00:54:09.000Z","date":"2024-02-01","kind":"grant","planned":true,"acquired":true,"shares":495100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":495100,"derivative":{"exercise_price":2.4,"expiration_date":"2034-02-01","underlying":"Common Shares","underlying_shares":495100},"source":{"system":"sec-edgar","filing":"0001447028-24-000025","document":"wk-form4_1707180834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000025/wk-form4_1707180834.xml","form_type":"4"}},{"id":1658661,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Common Shares","published_at":"2024-02-06T00:54:09.000Z","date":"2024-02-02","kind":"sale","planned":true,"acquired":false,"shares":10164,"price":2.3125,"value":23504.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 3, 2023,  to satisfy the Reporting Person's tax obligations with respect to the vesting of a previous grant of restricted stock units."}],"balance_after":1504793,"source":{"system":"sec-edgar","filing":"0001447028-24-000025","document":"wk-form4_1707180834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000025/wk-form4_1707180834.xml","form_type":"4"}},{"id":1658660,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Common Shares","published_at":"2024-02-06T00:54:09.000Z","date":"2024-02-01","kind":"grant","planned":true,"acquired":true,"shares":123800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":1514957,"source":{"system":"sec-edgar","filing":"0001447028-24-000025","document":"wk-form4_1707180834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000025/wk-form4_1707180834.xml","form_type":"4"}},{"id":1658799,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83058,"kind":"person","name":"Naftzger J. Christopher","position":1,"cik":"0001496194","reported_name":"Naftzger J. Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-05T19:55:14.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":380500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":380500,"derivative":{"exercise_price":2.4,"expiration_date":"2034-02-01","underlying":"Common Shares","underlying_shares":380500},"source":{"system":"sec-edgar","filing":"0001447028-24-000029","document":"wk-form4_1707180904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496194/000144702824000029/wk-form4_1707180904.xml","form_type":"4"}},{"id":1658798,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83058,"kind":"person","name":"Naftzger J. Christopher","position":1,"cik":"0001496194","reported_name":"Naftzger J. Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Shares","published_at":"2024-02-05T19:55:14.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":95100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":95100,"source":{"system":"sec-edgar","filing":"0001447028-24-000029","document":"wk-form4_1707180904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496194/000144702824000029/wk-form4_1707180904.xml","form_type":"4"}},{"id":1659350,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83069,"kind":"person","name":"Sims Karen","position":1,"cik":"0001984652","reported_name":"Sims Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-05T19:55:02.000Z","date":"2024-02-01","kind":"grant","planned":true,"acquired":true,"shares":403900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":403900,"derivative":{"exercise_price":2.4,"expiration_date":"2034-02-01","underlying":"Common Shares","underlying_shares":403900},"source":{"system":"sec-edgar","filing":"0001447028-24-000028","document":"wk-form4_1707180890.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1984652/000144702824000028/wk-form4_1707180890.xml","form_type":"4"}},{"id":1659349,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83069,"kind":"person","name":"Sims Karen","position":1,"cik":"0001984652","reported_name":"Sims Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2024-02-05T19:55:02.000Z","date":"2024-02-02","kind":"sale","planned":true,"acquired":false,"shares":4358,"price":2.3125,"value":10077.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 9, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of a previous grant of restricted stock units."}],"balance_after":125542,"source":{"system":"sec-edgar","filing":"0001447028-24-000028","document":"wk-form4_1707180890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1984652/000144702824000028/wk-form4_1707180890.xml","form_type":"4"}},{"id":1659348,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83069,"kind":"person","name":"Sims Karen","position":1,"cik":"0001984652","reported_name":"Sims Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2024-02-05T19:55:02.000Z","date":"2024-02-01","kind":"grant","planned":true,"acquired":true,"shares":101000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":129900,"source":{"system":"sec-edgar","filing":"0001447028-24-000028","document":"wk-form4_1707180890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1984652/000144702824000028/wk-form4_1707180890.xml","form_type":"4"}},{"id":1830252,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":90604,"kind":"person","name":"Rewolinski Melissa","position":1,"cik":"0001780206","reported_name":"Rewolinski Melissa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-13T20:13:43.000Z","date":"2023-07-12","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on July 12, 2023, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest and become exercisable in three equal annual installments beginning one year from the grant date."}],"balance_after":110000,"derivative":{"exercise_price":2.27,"expiration_date":"2033-07-12","underlying":"Common Shares","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001447028-23-000076","document":"wk-form4_1689279213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000076/wk-form4_1689279213.xml","form_type":"4"}},{"id":1831066,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83069,"kind":"person","name":"Sims Karen","position":1,"cik":"0001984652","reported_name":"Sims Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-12T16:50:46.000Z","date":"2023-07-10","kind":"grant","planned":false,"acquired":true,"shares":153640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":153640,"derivative":{"exercise_price":2.26,"expiration_date":"2033-07-10","underlying":"Common Shares","underlying_shares":153640},"source":{"system":"sec-edgar","filing":"0001447028-23-000070","document":"wk-form4_1689195036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1984652/000144702823000070/wk-form4_1689195036.xml","form_type":"4"}},{"id":1830920,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83058,"kind":"person","name":"Naftzger J. Christopher","position":1,"cik":"0001496194","reported_name":"Naftzger J. Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-12T16:12:29.000Z","date":"2023-07-10","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Issuer's common shares on the Nasdaq Stock Market on July 10, 2023, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the grant date and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":500000,"derivative":{"exercise_price":2.26,"expiration_date":"2033-07-10","underlying":"Common Shares","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001447028-23-000066","document":"wk-form4_1689192740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496194/000144702823000066/wk-form4_1689192740.xml","form_type":"4"}},{"id":1876668,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T20:27:54.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 24, 2023, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":55000,"derivative":{"exercise_price":2.56,"exercise_date":"2023-05-24","expiration_date":"2033-05-24","underlying":"Common Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001447028-23-000048","document":"wk-form4_1685132843.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000144702823000048/wk-form4_1685132843.xml","form_type":"4"}},{"id":1876389,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":69834,"kind":"person","name":"BURGESS DANIEL D","position":1,"cik":"0001239650","reported_name":"BURGESS DANIEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T20:22:45.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 24, 2023, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":55000,"derivative":{"exercise_price":2.56,"exercise_date":"2023-05-24","expiration_date":"2033-05-24","underlying":"Common Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001447028-23-000046","document":"wk-form4_1685132533.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000046/wk-form4_1685132533.xml","form_type":"4"}},{"id":1876388,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T20:18:08.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 24, 2023, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":55000,"derivative":{"exercise_price":2.56,"exercise_date":"2023-05-24","expiration_date":"2033-05-24","underlying":"Common Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001447028-23-000044","document":"wk-form4_1685132251.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000044/wk-form4_1685132251.xml","form_type":"4"}},{"id":1876387,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":32849,"kind":"person","name":"Torti Frank","position":1,"cik":"0001647805","reported_name":"Torti Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T20:12:14.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 24, 2023, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":55000,"derivative":{"exercise_price":2.56,"exercise_date":"2023-05-24","expiration_date":"2033-05-24","underlying":"Common Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001447028-23-000042","document":"wk-form4_1685131883.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000042/wk-form4_1685131883.xml","form_type":"4"}},{"id":1876386,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T20:06:54.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 24, 2023, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":55000,"derivative":{"exercise_price":2.56,"exercise_date":"2023-05-24","expiration_date":"2033-05-24","underlying":"Common Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001447028-23-000040","document":"wk-form4_1685131561.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000040/wk-form4_1685131561.xml","form_type":"4"}},{"id":2032765,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T21:12:10.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":334700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":334700,"derivative":{"exercise_price":2.9,"expiration_date":"2033-02-01","underlying":"Common Shares","underlying_shares":334700},"source":{"system":"sec-edgar","filing":"0001447028-23-000011","document":"wf-form4_167545871089009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000011/wf-form4_167545871089009.xml","form_type":"4"}},{"id":2032764,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Shares","published_at":"2023-02-03T21:12:10.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":83700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":1391157,"source":{"system":"sec-edgar","filing":"0001447028-23-000011","document":"wf-form4_167545871089009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000011/wf-form4_167545871089009.xml","form_type":"4"}},{"id":2032763,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T21:11:39.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":328700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":328700,"derivative":{"exercise_price":2.9,"expiration_date":"2033-02-01","underlying":"Common Shares","underlying_shares":328700},"source":{"system":"sec-edgar","filing":"0001447028-23-000010","document":"wf-form4_167545866810752.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000010/wf-form4_167545866810752.xml","form_type":"4"}},{"id":2032762,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2023-02-03T21:11:39.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":82200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":1385603,"source":{"system":"sec-edgar","filing":"0001447028-23-000010","document":"wf-form4_167545866810752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000010/wf-form4_167545866810752.xml","form_type":"4"}},{"id":2032761,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34527,"kind":"person","name":"HASTINGS DAVID C","position":1,"cik":"0001237401","reported_name":"HASTINGS DAVID C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T21:11:02.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":316000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":316000,"derivative":{"exercise_price":2.9,"expiration_date":"2033-02-01","underlying":"Common Shares","underlying_shares":316000},"source":{"system":"sec-edgar","filing":"0001447028-23-000009","document":"wf-form4_167545863617086.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000009/wf-form4_167545863617086.xml","form_type":"4"}},{"id":2032760,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34527,"kind":"person","name":"HASTINGS DAVID C","position":1,"cik":"0001237401","reported_name":"HASTINGS DAVID C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2023-02-03T21:11:02.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":79000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":79000,"source":{"system":"sec-edgar","filing":"0001447028-23-000009","document":"wf-form4_167545863617086.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000009/wf-form4_167545863617086.xml","form_type":"4"}},{"id":2032757,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":117305,"kind":"person","name":"Collier William H.","position":1,"cik":"0001780495","reported_name":"Collier William H.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T21:10:34.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":866000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":866000,"derivative":{"exercise_price":2.9,"expiration_date":"2033-02-01","underlying":"Common Shares","underlying_shares":866000},"source":{"system":"sec-edgar","filing":"0001447028-23-000008","document":"wf-form4_167545861445606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000008/wf-form4_167545861445606.xml","form_type":"4"}},{"id":2032756,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":117305,"kind":"person","name":"Collier William H.","position":1,"cik":"0001780495","reported_name":"Collier William H.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2023-02-03T21:10:34.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":216500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":216500,"source":{"system":"sec-edgar","filing":"0001447028-23-000008","document":"wf-form4_167545861445606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000008/wf-form4_167545861445606.xml","form_type":"4"}},{"id":2032998,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":117310,"kind":"person","name":"Howard Elizabeth","position":1,"cik":"0001669530","reported_name":"Howard Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC, Compliance"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T16:10:11.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":278700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":278700,"derivative":{"exercise_price":2.9,"expiration_date":"2033-02-01","underlying":"Common Shares","underlying_shares":278700},"source":{"system":"sec-edgar","filing":"0001447028-23-000007","document":"wf-form4_167545859079631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669530/000144702823000007/wf-form4_167545859079631.xml","form_type":"4"}},{"id":2032997,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":117310,"kind":"person","name":"Howard Elizabeth","position":1,"cik":"0001669530","reported_name":"Howard Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC, Compliance"}}],"security":"Common Shares","published_at":"2023-02-03T16:10:11.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":69700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,324 common shares acquired pursuant to the Arbutus Biopharma Corporation 2020 Employee Stock Purchase Plan."}],"balance_after":86024,"source":{"system":"sec-edgar","filing":"0001447028-23-000007","document":"wf-form4_167545859079631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669530/000144702823000007/wf-form4_167545859079631.xml","form_type":"4"}},{"id":2255379,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T20:19:19.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 25, 2022, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":41000,"derivative":{"exercise_price":2.25,"exercise_date":"2022-05-25","expiration_date":"2032-05-25","underlying":"Common Shares","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001447028-22-000038","document":"wf-form4_165359633960254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000144702822000038/wf-form4_165359633960254.xml","form_type":"4"}},{"id":2255141,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":69834,"kind":"person","name":"BURGESS DANIEL D","position":1,"cik":"0001239650","reported_name":"BURGESS DANIEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T20:17:55.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 25, 2022, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":41000,"derivative":{"exercise_price":2.25,"exercise_date":"2022-05-25","expiration_date":"2032-05-25","underlying":"Common Shares","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001447028-22-000037","document":"wf-form4_165359625754672.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000037/wf-form4_165359625754672.xml","form_type":"4"}},{"id":2255142,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T20:16:24.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 25, 2022, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":41000,"derivative":{"exercise_price":2.25,"exercise_date":"2022-05-25","expiration_date":"2032-05-25","underlying":"Common Shares","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001447028-22-000036","document":"wf-form4_165359615932033.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000036/wf-form4_165359615932033.xml","form_type":"4"}},{"id":2255140,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":32849,"kind":"person","name":"Torti Frank","position":1,"cik":"0001647805","reported_name":"Torti Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T20:15:01.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 25, 2022, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":41000,"derivative":{"exercise_price":2.25,"exercise_date":"2022-05-25","expiration_date":"2032-05-25","underlying":"Common Shares","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001447028-22-000035","document":"wf-form4_165359607419806.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000035/wf-form4_165359607419806.xml","form_type":"4"}},{"id":2255139,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":126869,"kind":"person","name":"Tran Tram","position":1,"cik":"0001892918","reported_name":"Tran Tram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T20:13:28.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 25, 2022, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":41000,"derivative":{"exercise_price":2.25,"exercise_date":"2022-05-25","expiration_date":"2032-05-25","underlying":"Common Shares","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001447028-22-000034","document":"wf-form4_165359597719078.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000034/wf-form4_165359597719078.xml","form_type":"4"}},{"id":2255138,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T20:10:59.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 25, 2022, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":41000,"derivative":{"exercise_price":2.25,"exercise_date":"2022-05-25","expiration_date":"2032-05-25","underlying":"Common Shares","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001447028-22-000033","document":"wf-form4_165359582944568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000033/wf-form4_165359582944568.xml","form_type":"4"}},{"id":2430305,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":117305,"kind":"person","name":"Collier William H.","position":1,"cik":"0001780495","reported_name":"Collier William H.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T22:55:29.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":787550,"price":2.81,"value":2213015.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":787550,"derivative":{"exercise_price":2.81,"expiration_date":"2032-01-20","underlying":"Common Shares","underlying_shares":787550},"source":{"system":"sec-edgar","filing":"0001447028-22-000012","document":"wf-form4_164271931496383.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000012/wf-form4_164271931496383.xml","form_type":"4"}},{"id":2430304,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34527,"kind":"person","name":"HASTINGS DAVID C","position":1,"cik":"0001237401","reported_name":"HASTINGS DAVID C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T22:55:10.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":285000,"price":2.81,"value":800850.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":285000,"derivative":{"exercise_price":2.81,"expiration_date":"2032-01-20","underlying":"Common Shares","underlying_shares":285000},"source":{"system":"sec-edgar","filing":"0001447028-22-000011","document":"wf-form4_164271929611191.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000011/wf-form4_164271929611191.xml","form_type":"4"}},{"id":2430303,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T22:54:28.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":285000,"price":2.81,"value":800850.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":285000,"derivative":{"exercise_price":2.81,"expiration_date":"2032-01-20","underlying":"Common Shares","underlying_shares":285000},"source":{"system":"sec-edgar","filing":"0001447028-22-000009","document":"wf-form4_164271925075900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000009/wf-form4_164271925075900.xml","form_type":"4"}},{"id":2430302,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":131218,"kind":"person","name":"Picchio Gaston","position":1,"cik":"0001755014","reported_name":"Picchio Gaston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T22:54:07.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":256500,"price":2.81,"value":720765.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":256500,"derivative":{"exercise_price":2.81,"expiration_date":"2032-01-20","underlying":"Common Shares","underlying_shares":256500},"source":{"system":"sec-edgar","filing":"0001447028-22-000008","document":"wf-form4_164271923431244.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000008/wf-form4_164271923431244.xml","form_type":"4"}}],"next_cursor":"2022-01-20T22:54:07.000000Z,2430302"}